LGT Capital Partners LTD. lessened its stake in Colgate-Palmolive Company (NYSE:CL – Free Report) by 21.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 604,362 shares of the company’s stock after selling 161,340 shares during the period. Colgate-Palmolive comprises approximately 2.4% of LGT Capital Partners LTD.’s portfolio, making the stock its 16th largest position. LGT Capital Partners LTD. owned 0.07% of Colgate-Palmolive worth $47,757,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in CL. Brighton Jones LLC increased its holdings in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares during the last quarter. Woodline Partners LP increased its holdings in Colgate-Palmolive by 76.3% in the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after purchasing an additional 20,062 shares during the last quarter. Schnieders Capital Management LLC. increased its holdings in Colgate-Palmolive by 2.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after purchasing an additional 245 shares during the last quarter. Nebula Research & Development LLC increased its holdings in Colgate-Palmolive by 165.5% in the 2nd quarter. Nebula Research & Development LLC now owns 10,326 shares of the company’s stock valued at $939,000 after purchasing an additional 6,437 shares during the last quarter. Finally, Sei Investments Co. increased its holdings in Colgate-Palmolive by 21.7% in the 2nd quarter. Sei Investments Co. now owns 657,093 shares of the company’s stock valued at $59,732,000 after purchasing an additional 116,968 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Analysts Set New Price Targets
Several analysts recently weighed in on CL shares. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. JPMorgan Chase & Co. boosted their price target on shares of Colgate-Palmolive from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, May 4th. TD Cowen restated a “hold” rating and issued a $85.00 price target on shares of Colgate-Palmolive in a research note on Tuesday, March 31st. The Goldman Sachs Group restated a “buy” rating on shares of Colgate-Palmolive in a research note on Friday, May 1st. Finally, Weiss Ratings upgraded shares of Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, May 4th. Twelve investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $95.88.
Colgate-Palmolive Price Performance
Colgate-Palmolive stock opened at $86.01 on Tuesday. The stock has a market cap of $68.83 billion, a P/E ratio of 33.47, a price-to-earnings-growth ratio of 4.60 and a beta of 0.33. The company has a fifty day simple moving average of $86.53 and a 200-day simple moving average of $86.03. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.03. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.91 EPS. Equities analysts expect that Colgate-Palmolive Company will post 3.82 EPS for the current fiscal year.
Colgate-Palmolive Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, April 20th were given a dividend of $0.53 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend was Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.5%. Colgate-Palmolive’s dividend payout ratio is presently 82.49%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
